First Time Loading...

Immunoprecise Antibodies Ltd
XTSX:IPA

Watchlist Manager
Immunoprecise Antibodies Ltd Logo
Immunoprecise Antibodies Ltd
XTSX:IPA
Watchlist
Price: 6.5 CAD 0.78% Market Closed
Updated: May 5, 2024

Immunoprecise Antibodies Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immunoprecise Antibodies Ltd
Revenue Peer Comparison

Comparables:
ABCL
ARCH
RP
IOT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Immunoprecise Antibodies Ltd
XTSX:IPA
Revenue
CA$17.9m
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abcellera Biologics Inc
NASDAQ:ABCL
Revenue
$38m
CAGR 3-Years
-45%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Revenue
CA$4.9m
CAGR 3-Years
239%
CAGR 5-Years
N/A
CAGR 10-Years
62%
Replicel Life Sciences Inc
XTSX:RP
Revenue
CA$353.7k
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-22%
Innovotech Inc
XTSX:IOT
Revenue
CA$1.1m
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
2%

See Also

What is Immunoprecise Antibodies Ltd's Revenue?
Revenue
17.9m CAD

Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Revenue amounts to 17.9m CAD.

What is Immunoprecise Antibodies Ltd's Revenue growth rate?
Revenue CAGR 3Y
49%

Over the last year, the Revenue growth was 27%. The average annual Revenue growth rates for Immunoprecise Antibodies Ltd have been 49% over the past three years .